Published in Virology on April 28, 1997
Listeria-based vaccines can overcome tolerance by expanding low avidity CD8+ T cells capable of eradicating a solid tumor in a transgenic mouse model of cancer. Cancer Immun (2007) 1.06
Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16. Clin Exp Immunol (1999) 0.94
Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein. Immunology (2002) 0.85
Human papillomavirus type 16 E7 DNA vaccine: mutation in the open reading frame of E7 enhances specific cytotoxic T-lymphocyte induction and antitumor activity. J Virol (1999) 0.81
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology (1991) 3.28
20 years of hospital admissions for peptic ulcer in England and Wales. Lancet (1981) 3.06
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J Gen Virol (1993) 2.42
Genetic and environmental causes of variation in basal levels of blood cells. Twin Res (1999) 2.36
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Catecholamine secretion from digitonin-treated adrenal medullary chromaffin cells. J Biol Chem (1983) 2.10
'Speaking valve' aspiration in a laryngectomy patient. Anaesth Intensive Care (2010) 1.95
Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet (1986) 1.95
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J Virol (1994) 1.83
Genome organization of porcine epidemic diarrhoea virus. Adv Exp Med Biol (1993) 1.78
Evaluation of a 2% chlorhexidine gluconate in 70% isopropyl alcohol skin disinfectant. J Hosp Infect (2005) 1.78
Complete sequence (20 kilobases) of the polyprotein-encoding gene 1 of transmissible gastroenteritis virus. Virology (1995) 1.70
Transmission of human papillomaviruses from mother to child. Aust N Z J Obstet Gynaecol (1993) 1.63
A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow. Leuk Res (1985) 1.61
Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology (2000) 1.56
An outbreak of Serratia marcescens on the neonatal unit: a tale of two clones. J Hosp Infect (2006) 1.53
The values history: an innovation in surrogate medical decision-making. Law Med Health Care (1990) 1.50
Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology (1999) 1.45
Infection risk associated with a closed luer access device. J Hosp Infect (2006) 1.40
On the appropriateness of marginal models for repeated measurements in clinical trials. Stat Med (1998) 1.40
Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34+ cells. Leukemia (1992) 1.39
DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology (1998) 1.33
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect (2002) 1.31
The use of the internal perimeter to compare airway size and to calculate smooth muscle shortening. Am Rev Respir Dis (1988) 1.27
Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens. J Immunol (1985) 1.25
Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J Immunol (1998) 1.21
Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. Virology (1991) 1.21
18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol (2000) 1.21
HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background. Oncogene (2007) 1.21
A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc Natl Acad Sci U S A (1991) 1.19
Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol (1999) 1.17
Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. Virology (1997) 1.16
The glyceraldehyde-3-phosphate dehydrogenase gene family in the nematode, Caenorhabditis elegans: isolation and characterization of one of the genes. Biochim Biophys Acta (1987) 1.12
HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine (2000) 1.11
Epidemiology, clinical and laboratory characteristics of Staphylococcus aureus bacteraemia in a university hospital in UK. J Hosp Infect (2006) 1.09
[Long-term influence of associated arthrodesis on adjacent segments in the treatment of lumbar stenosis: a series of 127 cases with 9-year follow-up]. Rev Chir Orthop Reparatrice Appar Mot (2000) 1.08
Molecular phylogeny of eastern Pacific sea cucumbers (Echinodermata: Holothuroidea) based on mitochondrial DNA sequence. Mol Phylogenet Evol (1996) 1.07
Haemodynamic consequences of etomidate administration in elective cardiac surgery: a randomized double-blinded study. Br J Anaesth (2011) 1.07
Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice. Virology (1998) 1.05
The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology (1992) 1.02
Respiratory epithelial permeability after cigarette smoke exposure in guinea pigs. J Appl Physiol (1985) (1989) 1.02
Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. Virology (1996) 1.01
Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids. Virology (1999) 1.00
Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. Virology (2001) 1.00
Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J Gen Virol (1990) 1.00
BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology (2000) 1.00
IS1397 is active for transposition into the chromosome of Escherichia coli K-12 and inserts specifically into palindromic units of bacterial interspersed mosaic elements. J Bacteriol (1999) 0.99
Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen. Vaccine (1996) 0.99
Association of bovine papillomavirus type 1 with microtubules. Virology (2001) 0.98
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr (2005) 0.97
Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes. Eur J Immunol (1998) 0.97
Hypoxaemia after cardiac surgery: clinical application of a model of pulmonary gas exchange. Eur J Anaesthesiol (2004) 0.97
Comparison of the genetic determinism of two key phenological traits, flowering and maturity dates, in three Prunus species: peach, apricot and sweet cherry. Heredity (Edinb) (2012) 0.96
Identification, characterization and quantitation of pyrogenic polycylic aromatic hydrocarbons and other organic compounds in tire fire products. J Chromatogr A (2006) 0.96
Increased expression of Ia antigens on B cells after neonatal induction of lymphoid chimerism in mice: role of interleukin 4. Eur J Immunol (1990) 0.95
T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus. Clin Exp Immunol (1982) 0.95
Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16. Clin Exp Immunol (1999) 0.94
Quality assurance in preschool surveillance. Arch Dis Child (1994) 0.94
Comparison between principal component analysis and independent component analysis in electroencephalograms modelling. Biom J (2007) 0.94
Improved detection of immune complexes in human and mouse serum using a microassay adaptation of the C1Q binding test. J Immunol Methods (1979) 0.93
Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes. Virology (1998) 0.93
Surprising sun: a new step towards a complete picture? Phys Rev Lett (2004) 0.93
Major population differences in T cell response to a malaria sporozoite vaccine candidate. Int Immunol (1990) 0.93
A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11. Genes Immun (2004) 0.92
A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants. Clin Exp Immunol (1995) 0.92
Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice. Clin Exp Immunol (1988) 0.92
[Long-term outcome at adjacent levels of lumbar arthrodesis]. Rev Chir Orthop Reparatrice Appar Mot (1997) 0.92
Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort. Bone Marrow Transplant (2009) 0.91
Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure. J Immunol (2001) 0.91
Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific. J Gen Virol (1994) 0.91
Ultrastructural variation of Blastocystis hominis stocks in culture. Int J Parasitol (1989) 0.91
Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH. Clin Exp Immunol (1983) 0.91
Pleuroperitoneal effusion without ascites. Med J Aust (1983) 0.91
Purification, characterization and cDNA sequence of an alkaline chymotrypsin from the midgut of Manduca sexta. Insect Biochem Mol Biol (1995) 0.90
Calcium-regulated phosphorylation in synaptosomal cytosol: dependence on calmodulin. Proc Natl Acad Sci U S A (1980) 0.90
The nursing process: the effect on patients' satisfaction with nursing care. J Adv Nurs (1987) 0.90
Protein and DNA evidence for two demes of Blastocystis hominis from humans. Int J Parasitol (1992) 0.89
Spontaneous reverse hemolytic plaque formation. III. Monocyte-mediated suppression of elevated plaque formation in autoimmune disease. Clin Immunol Immunopathol (1982) 0.89
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine (2001) 0.89
Angiosarcoma of the breast. Initial misdiagnosis is still common. Arch Surg (1995) 0.89
A new approach to the classification of human leukaemias: measurement of the relative abundance of a specific RNA sequence by means of molecular hybridisation. Lancet (1983) 0.89
The cystine-stabilized alpha-helix: a common structural motif of ion-channel blocking neurotoxic peptides. Biopolymers (1991) 0.88
Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. Vaccine (2000) 0.88
Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice. Virology (1994) 0.88
Human papillomavirus--a study of male sexual partners. Med J Aust (1988) 0.88
Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology (1998) 0.88
Model-based identification of PEEP titrations during different volemic levels. Comput Methods Programs Biomed (2008) 0.87
Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter. J Virol (2001) 0.87
Glycosylation of human papillomavirus type 16 L1 protein. Virology (1993) 0.87
Variation in myc gene amplification and expression in sublines of HL60 cells. Leuk Res (1985) 0.87